Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. November 2022 12:18 ET | Quelle: Roots Analysis

The opportunity within the cytotoxic drugs and HPAPI manufacturing market is projected to grow at an annualized rate of ~12%, till 2035, claims Roots Analysis

London, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cytotoxic Drugs and HPAPI Manufacturing Market (4th Edition), 2022 – 2035” report to its list of offerings. ...
02. September 2021 08:00 ET | Quelle: Celsion CORP

Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform

Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery...
05. November 2013 10:45 ET | Quelle: Research and Markets

Closed Drug Transfer Systems - Therapeutic Markets, Strategies and Outlook

Dublin, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/x53tf3/closed_drug) has announced the addition of the "Closed Drug Transfer Systems....
12. Mai 2011 13:00 ET | Quelle: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011

PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...